DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksSchließen
Referenz
Schmitt-Hoffmann A, Roos B, Heep M. , et al.
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.
Antimicrob Agents Chemother 2006;
50 (01) 279-285
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.